(Q48489390)

12 February 2018

title

Effects of topiramate on the prepulse inhibition of the acoustic startle in rats. (English)

1 reference

12 February 2018

author

Roberto Frau

1

1 reference

12 February 2018

Mauro Fà

3

1 reference

12 February 2018

Marco Bortolato

9

1 reference

12 February 2018

author name string

Marco Orrù

2

1 reference

12 February 2018

Alberto Casti

4

1 reference

12 February 2018

Mario Manunta

5

1 reference

12 February 2018

Nicola Fais

6

1 reference

12 February 2018

Giampaolo Mereu

7

1 reference

12 February 2018

Gianluigi Gessa

8

1 reference

12 February 2018

language of work or name

English

0 references

publication date

14 June 2006

1 reference

12 February 2018

published in

Neuropsychopharmacology

1 reference

12 February 2018

volume

32

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

320-331

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301115

exact match

0 references

cites work

Control of Tourette's syndrome with topiramate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Current research on rapid cycling bipolar disorder and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Combination treatment of clozapine and topiramate in resistant rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

The rationale and use of topiramate for treating neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate antagonizes MK-801 in an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Presidential Address, 1974. The more or less startling effects of weak prestimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Executive and social behaviors under nicotinic receptor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Hypomania with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Acute psychotic symptoms induced by topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Dopaminergic stimulation disrupts sensorimotor gating in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate for refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate and psychiatric adverse events in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate selectively attenuates nicotine-induced increases in monoamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate monotherapy in epilepsy and migraine prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Acute psychotic disorders induced by topiramate: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Topiramate as add-on treatment for patients with bipolar mania

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Measurement of an explosive behavior in the mouse, induced by MK-801, a PCP analogue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Antimanic Efficacy of Topiramate in 11 Patients in an Open Trial With an On-Off-On Design

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Auditory hallucinations associated with topiramate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Topiramate: pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

trans-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D(2)/D(4) receptor antagonists as potential antipsychotic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301115

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301115

1 reference

12 February 2018

Dimensions Publication ID

1030944669

0 references

1 reference

12 February 2018